Filing Flows › GE HealthCare Technologies (GEHC) › Q3 2026 › vs Q3 2025
GE HealthCare Technologies (GEHC) Q3 2026 vs Q3 2025 (year over year)
GE HealthCare Technologies's revenue rose $370M (+7%) from $5.1B in Q3 2025 to $5.5B in Q3 2026. The biggest changes: Product +$227M (+7%); Service +$142M (+8%). Gross margin 40.3% against 38.7% (+1.6 pts).
GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%, net earnings $615M, operating cash flow $907M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 40.3% | 38.7% | +1.6 pts |
| Operating margin | 14.6% | 12.7% | +1.9 pts |
| Net margin | 11.2% | 8.7% | +2.5 pts |
| Free cash flow margin | 14.4% | 9.4% | +5.0 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product | $3.6B | $3.4B | $227M | +7% |
| Service | $1.9B | $1.8B | $142M | +8% |
| Revenue | $5.5B | $5.1B | $370M | +7% |
| Gross profit | $2.2B | $2.0B | $234M | +12% |
| Cost of revenue | $3.3B | $3.2B | $136M | +4% |
| Operating profit | $805M | $653M | $152M | +23% |
| Operating expenses | $1.4B | $1.3B | $82.0M | +6% |
| Pre-tax earnings | $752M | $643M | $109M | +17% |
| Other expense, net | $53.0M | $10.0M | $43.0M | +430% |
| Research & development | $320M | $292M | $28.0M | +10% |
| SG&A | $1.1B | $1.0B | $55.0M | +5% |
| Net earnings | $615M | $446M | $169M | +38% |
| Minority interests | $8.0M | $18.0M | −$10.0M | -56% |
| Income tax | $129M | $179M | −$50.0M | -28% |
| Depreciation & amortization | $163M | $149M | $14.0M | +9% |
| Share-based compensation | $36.0M | $38.0M | −$2.0M | -5% |
| Working capital & other | $93.0M | −$40.0M | $133M | — |
| Operating cash flow | $907M | $593M | $314M | +53% |
| Free cash flow (OCF − capex) | $793M | $483M | $310M | +64% |
| Capital expenditures | $114M | $110M | $4.0M | +4% |
Questions
How much did GE HealthCare Technologies's revenue grow year over year in Q3 2026?
GE HealthCare Technologies's revenue rose $370M (+7%) from $5.1B in Q3 2025 to $5.5B in Q3 2026.
What drove GE HealthCare Technologies's revenue change in Q3 2026?
Product +$227M (+7%); Service +$142M (+8%).